BioCentury
ARTICLE | Company News

Pilot program for GSK's malaria vaccine starts in Malawi

April 23, 2019 8:00 PM UTC

WHO launched a planned pilot program of GSK's malaria vaccine RTS,S in Malawi on Tuesday with the goal of informing the organization's policy recommendations for broader use of the vaccine. The organization will also roll out the pilot in Ghana and Kenya in the coming weeks. The program aims to administer the vaccine to about 360,000 children up to 2 years of age across the three countries per year.

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) is donating up to 10 million vaccine doses for the pilot...